Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (listing Obligations and Disclosure Requirements), Regulations, 2015 (Listing Regulations), Genpharmasec has informed that the Board of Directors have considered, accepted and passed the resolution by circular motion on Tuesday 11th October, 2022, thereby accepting Amisha Dani's resignation from the post of Non-executive Independent Director of the Company. The Company has enclosed her resignation letter with reasons for her resignation, for records.
The above information is a part of company’s filings submitted to BSE.
